Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Synthesis, structural investigations, hydrogen-deuterium exchange studies, and molecular modeling of conformationally stablilized aromatic oligoamides.

Yan Y, Qin B, Ren C, Chen X, Yip YK, Ye R, Zhang D, Su H, Zeng H.

J Am Chem Soc. 2010 Apr 28;132(16):5869-79. doi: 10.1021/ja100579z.

PMID:
20364840
2.

Helical organization in foldable aromatic oligoamides by a continuous hydrogen-bonding network.

Yan Y, Qin B, Shu Y, Chen X, Yip YK, Zhang D, Su H, Zeng H.

Org Lett. 2009 Mar 19;11(6):1201-4. doi: 10.1021/ol802679p.

PMID:
19222182
3.

Crystallographic evidence of an unusual, pentagon-shaped folding pattern in a circular aromatic pentamer.

Qin B, Chen X, Fang X, Shu Y, Yip YK, Yan Y, Pan S, Ong WQ, Ren C, Su H, Zeng H.

Org Lett. 2008 Nov 20;10(22):5127-30. doi: 10.1021/ol801980h. Epub 2008 Oct 18.

PMID:
18928289
4.

Rapid analysis of pseudolaric acids in Cortex Pseudolaricis and related medicinal products by high performance liquid chromatography.

Han QB, Yip YK, Yang NY, Wong L, Qiao CF, Song JZ, Yiu H, Xu HX.

Talanta. 2007 Oct 15;73(4):757-63. doi: 10.1016/j.talanta.2007.04.047. Epub 2007 May 10.

PMID:
19073098
6.

Rapid determination of polyprenylated xanthones in gamboge resin of Garcinia hanburyi by HPLC.

Song JZ, Yip YK, Han QB, Qiao CF, Xu HX.

J Sep Sci. 2007 Feb;30(3):304-9.

PMID:
17396587
7.

Chronically HIV-1-infected monocytic cells induce apoptosis in cocultured T cells.

Chen H, Yip YK, George I, Tyorkin M, Salik E, Sperber K.

J Immunol. 1998 Oct 15;161(8):4257-67. Erratum in: J Immunol. 2005 Dec 15;175(12):8443-4. Retraction in: Chen H, George I, Tyorkin M, Salik E, Sperber K. J Immunol. 2006 Nov 1;177(9):6560.

8.

Absence of neutralizing antibodies to interferon in condyloma acuminata and cancer patients treated with natural human leukocyte interferon.

Liao MJ, Axelrod HR, Kuchler M, Yip YK, Kirkbright E, Testa D.

J Infect Dis. 1992 Apr;165(4):757-60.

PMID:
1552208
10.

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions.

Gimbrone MA Jr, Obin MS, Brock AF, Luis EA, Hass PE, H├ębert CA, Yip YK, Leung DW, Lowe DG, Kohr WJ, et al.

Science. 1989 Dec 22;246(4937):1601-3.

PMID:
2688092
11.
13.

Toxicity of enzymically-oxidized low-density lipoprotein.

Bernheimer AW, Robinson WG, Linder R, Mullins D, Yip YK, Cooper NS, Seidman I, Uwajima T.

Biochem Biophys Res Commun. 1987 Oct 14;148(1):260-6.

PMID:
3479114
14.

Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.

Tsujimoto M, Yip YK, Vilcek J.

J Immunol. 1986 Apr 1;136(7):2441-4.

PMID:
3005410
15.

Induction of human interferon gamma with phorbol esters and phytohemagglutinin.

Vilcek J, Le JM, Yip YK.

Methods Enzymol. 1986;119:48-54. No abstract available.

PMID:
3093810
16.

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Tsujimoto M, Yip YK, Vilcek J.

Proc Natl Acad Sci U S A. 1985 Nov;82(22):7626-30.

17.

Cloning and expression of a novel variant of human interferon-gamma cDNA.

Nishi T, Fujita T, Nishi-Takaoka C, Saito A, Matsumoto T, Sato M, Oka T, Itoh S, Yip YK, Vilcek J, et al.

J Biochem. 1985 Jan;97(1):153-9.

18.

Monoclonal antibodies as structural probes for oligomeric human interferon-gamma.

Le J, Chang TW, Liu V, Yip YK, Vilcek J.

J Interferon Res. 1985 Summer;5(3):445-53.

PMID:
2414374
19.

Cytolytic activity of interferon-gamma and its synergism with 5-fluorouracil.

Le J, Yip YK, Vilcek J.

Int J Cancer. 1984 Oct 15;34(4):495-500.

PMID:
6436183
20.

Three molecular weight forms of natural human interferon-gamma revealed by immunoprecipitation with monoclonal antibody.

Kelker HC, Le J, Rubin BY, Yip YK, Nagler C, Vilcek J.

J Biol Chem. 1984 Apr 10;259(7):4301-4.

21.

Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.

Stone-Wolff DS, Yip YK, Kelker HC, Le J, Henriksen-Destefano D, Rubin BY, Rinderknecht E, Aggarwal BB, Vilcek J.

J Exp Med. 1984 Mar 1;159(3):828-43.

22.

Structure and function of human interferon-gamma.

Vilcek J, Kelker HC, Le J, Yip YK.

Symp Fundam Cancer Res. 1984;37:299-313. No abstract available.

PMID:
6441990
23.

Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.

Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J.

J Immunol. 1983 Dec;131(6):2821-6.

PMID:
6417232
24.

Stimulation of lymphokine production by teleocidin, aplysiatoxin, and debromoaplysiatoxin.

Yip YK, Kelker HC, Stone-Wolff DS, Pearlstein K, Urban C, Vilcek J.

Cell Immunol. 1983 Jul 15;79(2):389-95.

PMID:
6409425
25.
26.

Human interferon-gamma is internalized and degraded by cultured fibroblasts.

Anderson P, Yip YK, Vilcek J.

J Biol Chem. 1983 May 25;258(10):6497-502.

27.

Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts.

Anderson P, Yip YK, Vilcek J.

J Biol Chem. 1982 Oct 10;257(19):11301-4.

28.

Purification of two subspecies of human gamma (immune) interferon.

Yip YK, Barrowclough BS, Urban C, Vilcek J.

Proc Natl Acad Sci U S A. 1982 Mar;79(6):1820-4.

29.

Molecular weight of human gamma interferon is similar to that of other human interferons.

Yip YK, Barrowclough BS, Urban C, Vilcek J.

Science. 1982 Jan 22;215(4531):411-3.

PMID:
6173921
30.

Immune interferon induction by monoclonal antibody specific for human T cells.

Pang RH, Yip YK, Vilcek J.

Cell Immunol. 1981 Nov 1;64(2):304-11. No abstract available.

PMID:
6171356
31.

Stimulation of human gamma interferon production by diterpene esters.

Yip YK, Pang RH, Oppenheim JD, Nachbar MS, Henriksen D, Zerebeckyj-Eckhardt I, Vilcek J.

Infect Immun. 1981 Oct;34(1):131-9.

32.

Partial characterization of gamma (immune) interferon mRNA extracted from human lymphocytes.

Taniguchi T, Pang RH, Yip YK, Henriksen D, Vilcek J.

Proc Natl Acad Sci U S A. 1981 Jun;78(6):3469-72.

33.

Partial purification and characterization of human gamma (immune) interferon.

Yip YK, Pang RH, Urban C, Vilcek J.

Proc Natl Acad Sci U S A. 1981 Mar;78(3):1601-5.

34.

Stimulation of gamma interferon production by TPA and related diterpene esters.

Vilcek J, Yip YK, Stone-Wolff DS, Pang RH.

Tex Rep Biol Med. 1981-1982;41:108-15. No abstract available.

PMID:
6817435
35.

Production of human fibroblast interferon in the presence of the glycosylation inhibitor tunicamycin.

Yip YK, Vilcek J.

Methods Enzymol. 1981;78(Pt A):212-9. No abstract available.

PMID:
6173592
36.

Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.

Vilcek J, Sulea IT, Zerebeckyj IL, Yip YK.

J Clin Microbiol. 1980 Jan;11(1):102-5.

37.

Le interferon production by human fibroblasts.

Hayes TG, Yip YK, Vilcek J.

Virology. 1979 Oct 30;98(2):351-63. No abstract available.

PMID:
228476
38.

Characteristics of human lymphoblastoid (Namalva) interferon.

Havell EA, Yip YK, Vilcek J.

J Gen Virol. 1978 Jan;38(1):51-9.

PMID:
74402
39.

Correlation of physicochemical and antigenic properties of human leukocyte interferon subspecies.

Havell EA, Yip YK, Vilcek J.

Arch Virol. 1977;55(1-2):121-9. No abstract available.

PMID:
72554
40.
41.

Studies on catalytic properties of purified high molecular weight pancreatic lipase.

Yip YK, Ramachandran S, Wagle SR.

Proc Soc Exp Biol Med. 1975 Jul;149(3):683-7.

PMID:
1144458
43.
44.

Studies on the mechanism of inhibition of lipolysis by phenoxybenzamine.

Santhanam K, Yip YK, Ramachandran S, Allen DO, Wagle SR.

Life Sci II. 1971 Apr 22;10(8):437-42. No abstract available.

PMID:
5089342
45.

Studies on lipase. Isolation and purification of a high molecular weight pancreatic lipase.

Ramachandran S, Yip YK, Wagle SR.

Eur J Biochem. 1970 Feb;12(2):201-7. No abstract available.

46.

Protonation of tyrosyl residues in the carboxy derivatives of hemoglobin, its isolated subunits, and apohemoglobin.

Yip YK, Bucci E.

J Biol Chem. 1968 Nov 25;243(22):5948-52. No abstract available.

Supplemental Content

Support Center